A Clinical Study on a Novel Wound Dressing for Acute and Chronic Wounds

Publish Year: 1402
نوع سند: مقاله کنفرانسی
زبان: English
View: 70

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

WTRMED10_055

تاریخ نمایه سازی: 1 بهمن 1402

Abstract:

Objective: This clinical study aimed to evaluate the performance and safety of NanoEx wound dressing (Nano Fanavaran Narin teb Co., Iran) in the management of acute and chronic wounds. Methods: Forty patients suffering from wounds with different etiologies were enrolled. The wounds were evaluated for healing rate, wound area, wound bed tissue, exudate, and pain levels. Weekly assessments were done using wound evaluation forms and via digital photography. Results: After ۲۱.۲۵ days, wound area decreased by ۷۰.۶%, respectively, with a healing rate of ۵.۴۶ %/day. After ۹ weeks, ۵۷.۵% of wounds completely healed with a healing rate of ۵.۷ %/day. Wound-related pain and exudate met a significant (p < .۰۰۱) decrease, reducing by two and four points, respectively. The percentage of epithelialized tissue increased by ۵۷.۲%. Also, the percentage of slough and necrotic tissue decreased by more than ۹۰%, showing a significant decrease (p < ۰.۰۵). Conclusions: In general, NanoEx wound dressing was safe and efficient for the treatment of acute and chronic wounds

Authors

Ghazal Shariat Panahi

Nano Fanavaran Narin Teb Co., Tehran, Iran

Mohammad Darvishi

Infectious Diseases and Tropical Medicine Research Center (IDTMRC), Aerospace and subaquatic Medicine Faculty, AJAUMS, Tehran, Iran

Mehdi Akbarzadeh

Sadra Wound, Ostomy and Osteomyelitis Specialist Center, , Tehran, Iran

Maryam Barkhordari

Wound clinic of Imam Hussein Hospital Medical Center, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran

Amir Ghasemi

Nano Fanavaran Narin Teb Co., Tehran, Iran